Found: 13
Select item for more details and to access through your institution.
Development and In Vivo Application of a Water-Soluble Anticancer Copper Ionophore System Using a Temperature-Sensitive Liposome Formulation.
- Published in:
- Pharmaceutics, 2020, v. 12, n. 5, p. 466, doi. 10.3390/pharmaceutics12050466
- By:
- Publication type:
- Article
Horizontal Combination of MEK and PI3K/mTOR Inhibition in BRAF Mutant Tumor Cells with or without Concomitant PI3K Pathway Mutations.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 20, p. 7649, doi. 10.3390/ijms21207649
- By:
- Publication type:
- Article
The Antitumor Effect of Lipophilic Bisphosphonate BPH1222 in Melanoma Models: The Role of the PI3K/Akt Pathway and the Small G Protein Rheb.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 19, p. 4917, doi. 10.3390/ijms20194917
- By:
- Publication type:
- Article
Long-Term Vemurafenib Exposure Induced Alterations of Cell Phenotypes in Melanoma: Increased Cell Migration and Its Association with EGFR Expression.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 18, p. 4484, doi. 10.3390/ijms20184484
- By:
- Publication type:
- Article
Pan-RAF and MEK vertical inhibition enhances therapeutic response in non-V600 BRAF mutant cells.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Prenylation Inhibition-Induced Cell Death in Melanoma: Reduced Sensitivity in BRAF Mutant/PTEN Wild-Type Melanoma Cells.
- Published in:
- PLoS ONE, 2015, v. 10, n. 2, p. 1, doi. 10.1371/journal.pone.0117021
- By:
- Publication type:
- Article
Extracellular vesicles promote migration despite BRAF inhibitor treatment in malignant melanoma cells.
- Published in:
- Cell Communication & Signaling, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12964-024-01660-4
- By:
- Publication type:
- Article
HDAC Inhibition Induces PD-L1 Expression in a Novel Anaplastic Thyroid Cancer Cell Line.
- Published in:
- Pathology & Oncology Research, 2020, v. 26, n. 4, p. 2523, doi. 10.1007/s12253-020-00834-y
- By:
- Publication type:
- Article
Next Generation Lipophilic Bisphosphonate Shows Antitumor Effect in Colorectal Cancer In Vitro and In Vivo.
- Published in:
- Pathology & Oncology Research, 2020, v. 26, n. 3, p. 1957, doi. 10.1007/s12253-019-00789-9
- By:
- Publication type:
- Article
Sensitivity of Melanoma Cells to EGFR and FGFR Activation but Not Inhibition is Influenced by Oncogenic BRAF and NRAS Mutations.
- Published in:
- Pathology & Oncology Research, 2015, v. 21, n. 4, p. 957, doi. 10.1007/s12253-015-9916-9
- By:
- Publication type:
- Article
Histone Deacetylase Inhibitor Treatment Increases the Expression of the Plasma Membrane Ca<sup>2+</sup> Pump PMCA4b and Inhibits the Migration of Melanoma Cells Independent of ERK.
- Published in:
- Frontiers in Oncology, 2017, v. 7, p. 1, doi. 10.3389/fonc.2017.00095
- By:
- Publication type:
- Article
The plasma membrane Ca<sup>2+</sup> pump PMCA4b inhibits the migratory and metastatic activity of BRAF mutant melanoma cells.
- Published in:
- International Journal of Cancer, 2017, v. 140, n. 12, p. 2758, doi. 10.1002/ijc.30503
- By:
- Publication type:
- Article
Cisplatin and Pemetrexed Activate AXL and AXL Inhibitor BGB324 Enhances Mesothelioma Cell Death from Chemotherapy.
- Published in:
- Frontiers in Pharmacology, 2018, p. 1, doi. 10.3389/fphar.2017.00970
- By:
- Publication type:
- Article